These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7199380)

  • 1. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
    Ducore JM; Erickson LC; Zwelling LA; Laurent G; Kohn KW
    Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cytotoxicity and DNA cross-linking in normal and transformed human fibroblasts treated with cis-diamminedichloroplatinum(II).
    Erickson LC; Zwelling LA; Ducore JM; Sharkey NA; Kohn KW
    Cancer Res; 1981 Jul; 41(7):2791-4. PubMed ID: 7195771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alpha-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro.
    Ducore JM; McNamara L
    Cancer Res; 1986 Mar; 46(3):1068-72. PubMed ID: 3080230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA cross-linking and cytotoxicity induced by cis-diamminedichloroplatinum(II) in human normal and tumor cell lines.
    Laurent G; Erickson LC; Sharkey NA; Kohn KW
    Cancer Res; 1981 Sep; 41(9 Pt 1):3347-51. PubMed ID: 7196283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
    Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB
    Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
    Swinnen LJ; Barnes DM; Fisher SG; Albain KS; Fisher RI; Erickson LC
    Cancer Res; 1989 Mar; 49(6):1383-9. PubMed ID: 2924295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
    Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
    Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
    Aida T; Bodell WJ
    Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H; Drewinko B
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
    Bodenner DL; Dedon PC; Keng PC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2745-50. PubMed ID: 2870800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II).
    Meyn RE; Corry PM; Fletcher SE; Demetriades M
    Cancer Res; 1980 Apr; 40(4):1136-9. PubMed ID: 7188882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
    Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC
    Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.
    Micetich KC; Barnes D; Erickson LC
    Cancer Res; 1985 Sep; 45(9):4043-7. PubMed ID: 3896476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.
    Micetich K; Zwelling LA; Kohn KW
    Cancer Res; 1983 Aug; 43(8):3609-13. PubMed ID: 6683124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
    Murray D; Jenkins WT; Meyn RE
    Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II).
    Plooy AC; van Dijk M; Berends F; Lohman PH
    Cancer Res; 1985 Sep; 45(9):4178-84. PubMed ID: 3928152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
    Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA
    Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one.
    Gibson NW; Hickman JA; Erickson LC
    Cancer Res; 1984 May; 44(5):1772-5. PubMed ID: 6713381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of in vitro grown IgM immunocytoma cells to cis-diamminedichloroplatinum (II) (cis-DDP) and cross-resistance to other DNA interacting drugs.
    Vendrik CP; de Jong WH; Van der Minnen AC; Fichtinger-Schepman AM; Steerenberg PA; Schornagel JH
    Anticancer Res; 1990; 10(2A):447-52. PubMed ID: 2346318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theophylline does not reverse DNA replicon initiation inhibition in human cells resistant to alkylating agent-theophylline killing synergism.
    Ducore JM; Rosenstein BS
    Chem Biol Interact; 1984 Sep; 51(2):191-200. PubMed ID: 6540627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.